Matches in Wikidata for { <http://www.wikidata.org/entity/Q92476927> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q92476927 description "article scientifique publié en 2020" @default.
- Q92476927 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92476927 description "im Januar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92476927 description "scientific article published on 03 January 2020" @default.
- Q92476927 description "wetenschappelijk artikel" @default.
- Q92476927 description "наукова стаття, опублікована 3 січня 2020" @default.
- Q92476927 name "Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial" @default.
- Q92476927 name "Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial" @default.
- Q92476927 type Item @default.
- Q92476927 label "Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial" @default.
- Q92476927 label "Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial" @default.
- Q92476927 prefLabel "Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial" @default.
- Q92476927 prefLabel "Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial" @default.
- Q92476927 P1433 Q92476927-3CD0EE1C-4DF2-4606-8B51-DD9971426403 @default.
- Q92476927 P1476 Q92476927-457CBA13-5DF0-4529-BDE6-C53CF7A114B2 @default.
- Q92476927 P2093 Q92476927-0250B2F7-7B58-460E-B460-259C522287D0 @default.
- Q92476927 P2093 Q92476927-C963C9F0-8737-4FCC-8ABE-53BE7DB5808E @default.
- Q92476927 P2093 Q92476927-F3C3C7DD-BE98-4FDB-9E11-EF432A38373C @default.
- Q92476927 P304 Q92476927-3AE11000-BD74-417D-9EBD-58CE6994ABDB @default.
- Q92476927 P31 Q92476927-17812D4A-F1B8-49CC-AF59-FB83DF46D459 @default.
- Q92476927 P356 Q92476927-7180E8DB-CB63-4EC7-87EB-1E16342B235B @default.
- Q92476927 P433 Q92476927-A42B1AF4-FB40-476C-B9F3-ACE60D71B252 @default.
- Q92476927 P478 Q92476927-399463FD-561D-41BF-B499-1E5DCE88DD09 @default.
- Q92476927 P50 Q92476927-047E2C08-68FC-4B2C-9199-5EDB16434B0D @default.
- Q92476927 P50 Q92476927-539D4322-7375-480D-A3F2-CC232E6DA4BD @default.
- Q92476927 P50 Q92476927-544B5A25-AD4A-406C-9A0E-90B5DADC45E3 @default.
- Q92476927 P50 Q92476927-549F91E8-EE6B-4B9C-B0CA-BA6327B98A9F @default.
- Q92476927 P50 Q92476927-66BEB49D-AF74-40EF-A94E-ABB14F9C3D1C @default.
- Q92476927 P50 Q92476927-A392D0FB-34EE-4EF7-89BC-48766683423C @default.
- Q92476927 P50 Q92476927-C00B2B79-C445-457E-9B12-10BA03319D05 @default.
- Q92476927 P50 Q92476927-E96DE8A2-5EFB-4759-A214-425454452AC9 @default.
- Q92476927 P577 Q92476927-2F191E97-2BF2-4F3E-B24C-8D0AEC932140 @default.
- Q92476927 P698 Q92476927-86E69449-972A-45E3-A119-2FB0569BA9C5 @default.
- Q92476927 P921 Q92476927-0F4CC3BC-29EC-44FA-9BDA-15BCE414754F @default.
- Q92476927 P921 Q92476927-63C45CE6-1307-462D-B93D-6D6B832F8E4B @default.
- Q92476927 P356 J.EURURO.2019.12.019 @default.
- Q92476927 P698 31911010 @default.
- Q92476927 P1433 Q15763991 @default.
- Q92476927 P1476 "Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial" @default.
- Q92476927 P2093 "Andrea Gallina" @default.
- Q92476927 P2093 "Francesco Barletta" @default.
- Q92476927 P2093 "Renzo Colombo" @default.
- Q92476927 P304 "576-580" @default.
- Q92476927 P31 Q13442814 @default.
- Q92476927 P356 "10.1016/J.EURURO.2019.12.019" @default.
- Q92476927 P433 "5" @default.
- Q92476927 P478 "77" @default.
- Q92476927 P50 Q41202163 @default.
- Q92476927 P50 Q41492572 @default.
- Q92476927 P50 Q57569949 @default.
- Q92476927 P50 Q67191520 @default.
- Q92476927 P50 Q67191563 @default.
- Q92476927 P50 Q88616632 @default.
- Q92476927 P50 Q90236902 @default.
- Q92476927 P50 Q92476921 @default.
- Q92476927 P577 "2020-01-03T00:00:00Z" @default.
- Q92476927 P698 "31911010" @default.
- Q92476927 P921 Q111329312 @default.
- Q92476927 P921 Q13896859 @default.